Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug;112(14):1085-1092.
doi: 10.1002/bdr2.1711. Epub 2020 May 27.

Sinus pericranii, skull defects, and structural brain anomalies in TRAF7-related disorder

Affiliations
Case Reports

Sinus pericranii, skull defects, and structural brain anomalies in TRAF7-related disorder

Andrea Accogli et al. Birth Defects Res. 2020 Aug.

Abstract

Background: Several somatic mutations in TRAF7 have been reported in cancers, whereas a few germline heterozygous mutations have been recently linked to a neurodevelopmental disorder, characterized by craniofacial dysmorphisms, congenital heart defects, and digital anomalies.

Cases: We report two subjects harboring de novo heterozygous missense variants in TRAF7, namely the recurrent 1964G>A(p.Arg655Gln) and the novel missense c.1204C>G(p.Leu402Val) variants. In addition to the typical hallmarks of the TRAF7-related disorder, both subjects presented with a recognizable "pear-shaped" skull due to multiple craniosynostosis, sinus pericranii, skull base/cranio-cervical junction anomalies, dysgyria, and inferior cerebellar vermis hypoplasia.

Conclusions: Hence, we expand the genotypic and phenotypic spectrum of this neurodevelopmental disorder, discussing possible implications for clinical management of subjects with germline TRAF7 mutations.

Keywords: RASopathies; TRAF7; cranio-cervical junction anomaly; craniosynostosis; dysgyria; sinus pericranii.

PubMed Disclaimer

References

REFERENCES

    1. Arcila, M. E., Drilon, A., Sylvester, B. E., Lovly, C. M., Borsu, L., Reva, B., … Ladanyi, M. (2015). MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking. Clinical Cancer Research, 21, 1935-1943. https://doi.org/10.1158/1078-0432.CCR-14-2124
    1. Caunt, C. J., Sale, M. J., Smith, P. D., & Cook, S. J. (2015). MEK1 and MEK2 inhibitors and cancer therapy: The long and winding road. Nature Reviews. Cancer, 15, 577-592. https://doi.org/10.1038/nrc4000
    1. Cizmeci, M. N., Lequin, M., Lichtenbelt, K. D., Chitayat, D., Kannu, P., James, A. G., … de Vries, L. S. (2018). Characteristic MR imaging findings of the neonatal brain in RASopathies. AJNR. American Journal of Neuroradiology, 39, 1146-1152. https://doi.org/10.3174/ajnr.A5611
    1. Couto, J. A., Huang, A. Y., Konczyk, D. J., Goss, J. A., Fishman, S. J., Mulliken, J. B., … Greene, A. K. (2017). Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. American Journal of Human Genetics, 100, 546-554. https://doi.org/10.1016/j.ajhg.2017.01.018
    1. Couto, J. A., Vivero, M. P., Kozakewich, H. P., Taghinia, A. H., Mulliken, J. B., Warman, M. L., & Greene, A. K. (2015). A somatic MAP3K3 mutation is associated with verrucous venous malformation. American Journal of Human Genetics, 96, 480-486. https://doi.org/10.1016/j.ajhg.2015.01.007

Publication types

Substances

LinkOut - more resources